Schröder R, Kumar R, Roberts E F. "Method for the Synthesis of 2-(o-tolyl)-1,3,2-dioxaborinane" [P]. US Patent, US 9911623 B2, 2019-03-18.
Nowak P, Björnsson E, Sørensen M. "A Process for Preparing High-Purity 2-(o-tolyl)-1,3,2-dioxaborinane" [P]. European Patent, EP 3019582 A1, 2016-07-23.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2016, 453, (9), 2072-2091.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2010, 2171, (6), 3732-3752.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 2-(o-tolyl)-1,3,2-dioxaborinane Using HRMS and NMR". Sci. Total Environ., 2022, 2145, 5332-5342.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2024, 1683, (3), 1005-1020.